Umbilical cord blood stem cells - potential therapeutic tool for neural injuries and disorders

• Autorzy: Ali H. , Bahbahani H.
• Języki publikacji: EN

Abstrakty

EN

Brain limited self-renewal capability is the main element behind the seriousness of neurodegenerative diseases and neural injuries. Any possible attempts to use cell replacement-therapy approaches rely on; first, the ability of such cells to generate neural cells and tissues with developmental and functional similarities to human brain cells and second, development of safe and effective protocols for cells transplantations. Many recent studies showed that human umbilical cord blood stem cells have the potential to generate cells with neuronal characteristics. It has also been shown that these stem cells have a positive impact on animal models of neural injuries and diseases. Umbilical cord blood stem cells are a potential candidate for clinical therapies for neural injuries and neural degenerative diseases for which current mode of therapy is inadequate. In addition, they might provide an in-vitro model of parenchymal neural cells for toxicology and drugs testing research.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2010
• Tom: 70
• Numer: 3
• Opis fizyczny: p.316-324,ref.

Twórcy

autor

Ali H.

• Institute of Human Genetics, International Centre for Life, Newcastle University, U.K.
• Department of Pathology , Collage of Medicine, Kuwait University, The State of Kuwait

autor

Bahbahani H.

• Kuwait Institute for Scientific Research (KISR), The State of Kuwait

Bibliografia

• Ali H, Jurga M, Kurgonaite K, Forraz N, Mcguckin C (2009) Defined serum-free culturing conditions for neural tissue engineering of human cord blood stem cells. Acta Neurobiol Exp (Wars) 69: 12-23.
• Amariglio N, Hirshberg A, Scheithauer B W, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, Toren A, Constantini S, Rechavi G (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6: e1000029.
• Bachstetter D, Pabon M, Cole J, Hudson E, Sanberg R, Willing E, Bickford C, Gemma C (2008) Peripheral injection of human umbilical cord blood stimulates neu- rogenesis in the aged rat brain. BMC Neurosci 9: 22.
• Ballen K, Barker N, Stewart K, Greene F, Lane A (2008) Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14: 356-363.
• Basak O, Taylor V (2008) Stem cells of the adult mamma­lian brain and their niche. Cell Mol Life Sci 66: 1057­1072.
• Behzad-Behbahani A, Pouransari R, Tabei Z, Rahiminejad S, Robati M, Yaghobi R, Nourani H, Ramzi M, Farhadi- Andarabi A, Mojiri A, Rahsaz M, Banihashemi M, Zare N (2005) Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoi­etic stem cells in bone marrow transplantation. Transplant Proc 37: 3211-3212.
• Bhandari D, Seo K, Roh K, Jung J, Kang S, Kang K (2010) REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells. PLoS One 5: e10493.
• Buzanska L, Macha, E, Zabcocka B, Pojda Z, Domanska- Janik K (2002) Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci 115: 2131­2138.
• Chen J, Sanberg P, Li Y, Wang L, Lu M, Willing A, Sanchez- Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32: 2682-3688.
• Chen R, Ende N (2000) The potential for the use of mono- nuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 31: 21-30.
• Denner L, Bodenburg Y, Zhao J, Howe M, Cappo, Tilton R, Copland J, Forraz N, Mcguckin C, Urban R (2007) Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif 40: 367­380.
• Domanska-Janik K, Habich A, Sarnowska A, Janowski M (2006) Neural commitment of cord blood stem cells (HUCB-NSC/NP): therapeutic perspectives. Acta Neurobiol Exp (Wars) 66: 279-291.
• El-Bdri N, Hakki A, Saporta S, Liang X, Madhusodanan S, Willing A, Sanberg C, Sanberg R (2006) Cord blood mesenchymal stem cells: potential use in neurological disorders. Stem Cells Dev 15: 497-506.
• Ende M, Ende N (1972) Hematopoietic transplantation by means of fetal (cord) blood. A new method. Va Med Mon 99: 276-280.
• Ende N, Weinstein F, Chen R, Ende M (2000) Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 67: 53-59.
• Feldmann R Jr, Mattern R (2006) The human brain and its neural stem cells postmortem: from dead brains to live therapy. Int J Legal Med 120: 201-211.
• Forraz N, Pettengell R, Mcguckin C (2004) Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC- IC. Stem Cells 22: 100-108.
• Giorgetti A, Montserrat N, Rodriguez-Piza I, Azqueta C, Veiga A, Izpisua Belmonte J (2010) Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat Protoc 5: 811-820
• Gluckman E, Broxmeyer H, Auerbach, A, Friedman H, Douglas G, Devergie A, Esperou H, Thierry D, Socie G, Lehn P (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321: 1174­1178.
• Habich A, Jurga M, Markiewicz I, Lukomska B, Bany- Laszewicz U, Domanska-Janik K (2006) Early appear­ance of stem/progenitor cells with neural-like characteris­tics in human cord blood mononuclear fraction cultured in vitro. Exp Hematol 34: 914-925.
• Habisch H, Janowski , Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, Schwalenstocker B, Hermann A, Brenner R, Lukomska B, Domanska-Janik K, Ludolph A, Storch A (2007) Intrathecal application of neuroectoder- mally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 114: 1395-1406.
• Harris D (2008) Author reply to: Cord blood stem cells: worth the investment. Nat Rev Cancer, 8: 823.
• Harris T, Badowski M, Ahmad N, Gaballa M (2007) The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther 7: 1311-22.
• Huntriss J, Picton H (2008) Stability of genomic imprinting in embryonic stem cells: lessons from assisted reproduc­tive technology. Curr Stem Cell Res Ther 3: 107-16.
• Jeong J, Hong S, Gang E, Ahn C, Hwang S, Yang I, Han H, Kim H (2005) Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells 23: 584-93.
• Johansson C, Momma S, Clarke D, Risling M, Lendahl U, Frisen J (1999) Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96: 25-34.
• Jurga M, Lipkowski A, Lukomska B, Buzanska L, Kurzepa K, Sobanski T, Habich A, Coecke S, Gajkowska B, Domanska-Janik K (2009) Generation of functional neu­ral artificial tissue from human umbilical cord blood stem cells. Tissue Eng Part A 15: 365-372.
• Jurga M, Markiewicz I, Sarnowska A, Habich A, Kozlowska H, Lukomska B, Buzanska L, Domanska-Janik K (2006) Neurogenic potential of human umbilical cord blood: neural-like stem cells depend on previous long-term cul­ture conditions. J Neurosci Res 83: 627-37.
• Kang K, Kim S, Oh Y, Yu J, Kim K, Park H, Song C, Han H (2005) A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 7: 368-73.
• Kang X, Zang , Bao L, Li D, Xu X, Yu J (2006) Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro. Cell Biol Int 30: 569­75.
• Kastenberg Z, Odorico J (2008) Alternative sources of pluri- potency: science, ethics, and stem cells. Transplant Rev (Orlando) 22: 215-22.
• Kim S, Lee J, Kim J, Jung J, Seo K, Park S, Roh K, Lee R, Hong H, Kim S, Lee Y, Kim S, Kang K (2008) Surface modification of polydimethylsiloxane (PDMS) induced proliferation and neural-like cells differentiation of umbilical cord blood-derived mesenchymal stem cells. J Mater Sci Mater Med 19: 2953-2962.
• Klimanskaya I, Chung Y, Meisner L, Johnson J, West M, Lanza R (2005) Human embryonic stem cells derived without feeder cells. Lancet 365: 1636-41.
• Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R (2007) Derivation of human embryonic stem cells from single blastomeres. Nat Protoc 2: 1963-72.
• Kofidis T, Debruin J, Tanaka M, Zwierzchoniewska M, Weissman I, Fedoseyeva E, Haverich A, Robbins R (2005) They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte- based host immune response. Eur J Cardiothorac Surg 28: 461-6.
• Kogler G, Sensken S, Airey J, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg R, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan A, Colletti E, Almeida-Porada G, Muller H, Zanjani E, Wernet P (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200: 123-35.
• Korshunova I, Novitskaya V, Kiryushko D, Pedersen N, Kolkova K, Kropotova E, Mosevitsky M, Rayko M, Morrow J, Ginzburg I, Berezin V, Bock E (2007) GAP-43 regulates NCAM-180-mediated neurite outgrowth. J Neurochem 100: 1599-612.
• Krtolica A (2005) Stem cell: balancing aging and cancer. Int J Biochem Cell Biol, 37: 935-41.
• Kuci S, Kuci Z, Schmid S, Seitz G, Muller I, Dufke A, Leimig T, Murti G, Jurecic R, Schumm M, Lang P, Bruchelt G, Bader P, Klingebiel T, Niethammer D, Handgretinger R (2008) Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif 41: 12-27.
• Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, Czajka R, Wojakowski W, Machalinski B, Ratajczak M (2007) Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21: 297-303.
• Kuh S, Cho Y, Yoon D, Kim K, Ha Y (2005) Functional recovery after human umbilical cord blood cells trans­plantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 147: 985­992.
• Lee M, Moon Y, Yang M, Kim S, Jang I, Eom Y, Park J, Kim H, Song K, Park S, Lim H, Kim Y (2007) Neural differ­entiation of novel multipotent progenitor cells from cryo- preserved human umbilical cord blood. Biochem Biophys Res Commun 358: 637-643.
• Lim J, Park S, Oh J, Kim S, Jeong C, Jun J, Lee K, Oh W, Lee J, Jeun S (2008) Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/ Akt-dependent signaling pathways. J Neurosci Res 86: 2168-2178.
• Lu D, Sanberg P, Mahmood A, Li Y, Wang L, Sanchez- Ramos J, Chopp M (2002) Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11: 275-81.
• Ma N, Stamm C, Kaminski A, Li W, Kleine H, Muller-Hilke B, Zhang L, Ladilov Y, Egger D, Steinhoff G (2005) Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 66: 45-54.
• Mcguckin C, Forraz N, Baradez M, Basford C, Dickinson A, Navran S, Hartgerink J (2006) Embryonic-like stem cells from umbilical cord blood and potential for neural model­ing. Acta Neurobiol Exp (Wars) 66: 321-329.
• Mcguckin C, Basford C, Hanger K, Habibollah S, Forraz N (2007) Cord blood revelations: the importance of being a first born girl, big, on time and to a young mother! Early Hum Dev 83: 733-741.
• Mcguckin C, Forraz N (2008) Potential for access to embry­onic-like cells from human umbilical cord blood. Cell Prolif 41: S31-S40.
• Mcguckin C, Jurga M, Ali H, Strbad M, Forraz N (2008) Culture of embryonic-like stem cells from human umbili­cal cord blood and onward differentiation to neural cells in vitro. Nat Protoc 3: 1046-1055.
• Mcguckin P, Forraz N, Baradez M, Navran S, Zhao J, Urban R, Tilton R, Denner L (2005) Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 38: 245-55.
• Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth- Haerer A, Gantert M, Dinse H, Dermietzel R, Jensen A (2006) Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 59: 244-249.
• Mochizuki K, Kikuta A, Ito M, Akaihata M, Sano H, Ohto H, Hosoya M (2008) Successful unrelated cord blood transplantation for chronic granulomatous disease: A case report and review of the literature. Pediatr Transplant 13: 384-389.
• Orkin S, Wang J, Kim J, Chu J, Rao S, Theunissen W, Shen X, Levasseur D (2008) The Transcriptional Network Controlling Pluripotency in ES Cells. Cold Spring Harb Symp Quant Biol 73: 195-202.
• Palmer T, Schwartz P, Taupin P, Kaspar B, Stein S, Gage F (2001) Cell culture. Progenitor cells from human brain after death. Nature 411: 42-43.
• Panepucci A, Siufi L, Silva W Jr, Proto-Siquiera R, Neder L, Orellana M, Rocha V, Covas, D, Zago M (2004) Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22: 1263-1278.
• Peterson D (2002) Stem cells in brain plasticity and repair. Curr Opin Pharmacol 2: 34-42.
• Pipes B, Tsang T, Peng S, Fiederlein R, Graham M, Harris D (2006) Telomere length changes after umbilical cord blood transplant. Transfusion 46: 1038-1043.
• Ringden O, Okas M, Uhlin M, Uzunel M, Remberger M, Mattsson J (2008) Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Bone Marrow Transplant 42: 643-648.
• Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, De Lima M, Finke J, Frassoni F, Gluckman E (2004) Transplants of umbilical- cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351: 2276­2285.
• Rogers I, Casper F (2004) Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol 18: 893-908.
• Roobrouck V, Ulloa-Montoya F, Verfaillie C (2008) Self- renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 314: 1937-1944.
• Sanberg P, Willing A, Garbuzova-Davis S, Saporta S, Liu G, Sanberg C, Bickford P, Klasko S, El-Badri N (2005) Umbilical cord blood-derived stem cells and brain repair. Ann NY Acad Sci 1049: 67-83.
• Sapienza C (2002) Imprinted gene expression, transplanta­tion medicine, and the „other" human embryonic stem cell. Proc Natl Acad Sci USA 99: 10243-10245.
• Saporta S, Kim J, Willing A, Fu E, Davis C, Sanberg P (2003) Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res 12: 271-278.
• Scott C, Reijo R (2008) The road to pluripotence: the research response to the embryonic stem cell debate. Hum Mol Genet 17: R3-R9.
• Seo K, Lee S, Bhandari D, Roh K, Park S, So A, Jung J, Seo M, Kang S, Lee Y, Kang K (2009) OCT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem Biophys Res Commun 384: 120-125
• Slatter M, Bhattacharya A, Flood T, Abinun M, Cant A, Gennery A (2006) Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott- Aldrich syndrome. Pediatr Blood Cancer 47: 332-324.
• Slatter M, Gennery A (2006) Umbilical cord stem cell trans­plantation for primary immunodeficiencies. Expert Opin Biol Ther 6: 555-565.
• Solves P, Mirabet V, Perales A, Carbonell-Uberos F, Roig R (2008) Banking strategies for improving the hematopoi- etic stem cell content of umbilical cord blood units for transplantation. Curr Stem Cell Res Ther 3: 79-84.
• Sun W, Buzanska L, Domanska-Janik K, Salvi R, Stachowiak M (2005) Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells 23: 931-945.
• Swijnenburg R, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl D, Caffarelli A, De Bruin J, Fedoseyeva E, Robbins R (2005) Embryonic stem cell immunogenic- ity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112: I166-I172.
• Swijnenburg R, Schrepfer S, Govaert J, Cao F, Ransohoff K, Sheikh Y, Haddad M, Connolly A, Davis M, Robbins R, Wu J (2008) Immunosuppressive therapy mitigates immu- nological rejection of human embryonic stem cell xeno- grafts. Proc Natl Acad Sci USA 105: 12991-12996.
• Takenaka C, Nishishita N, Takada N, Jakt L, Kawamata S (2010) Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol 38: 154-162.
• Tarnowski M, Sieron A (2006) Adult stem cells and their abil­ity to differentiate. Med Sci Monit 12: RA154-RA163.
• Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V, Jones J (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
• Wang T, Tio M, Lee W, Beerheide W, Udolph G (2007) Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem Biophys Res Commun 357: 1021-1027.
• Watt S, Contreras M (2005) Stem cell medicine: umbilical cord blood and its stem cell potential. Semin Fetal Neonatal Med 10: 209-220.
• Werbowetski-Ogilvie T, Bosse M, Stewart M, Schnerch A, Ramos-Mejia V, Rouleau A, Wynder T, Smith M, Dingwall S, Carter T, Williams C, Harris C, Dolling J, Wynder C, Boreham D, Bhatia M (2009) Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 27: 91-97.

Uwagi

PL

Rekord w opracowaniu